The College of Community Health Sciences has announced a new graduate degree program, the Master of Science in Translational Science and Medicine, with the first class beginning in fall 2026.
Translational science bridges the gap between laboratory discoveries and clinical applications, helping to turn scientific findings into real-world medical solutions. The new degree program, which will be administered through the College’s Department of Translational Science and Medicine, is designed to educate students to move innovations from bench to bedside care, improving human health outcomes through applied research and collaboration.
Over 18 months, students will complete a combination of coursework and practical training. The master’s degree curriculum includes foundational classes in translational science, biostatistics and entrepreneurship, as well as elective courses in areas such as immunology, pharmacology and drug discovery. Students will also participate in industry internships, work with research partners and complete a culminating project focused on addressing real-world challenges.
Graduates of the program will be prepared for careers in biomedical or pharmaceutical research, or for further study in medical or doctoral programs.
Dr. Ravi Kumar, chair of the Department of Translational Science and Medicine and Distinguished University Research Professor, said the program was developed in response to a growing need for professionals who can bridge science and clinical practice.
“Our cutting-edge, interdisciplinary curriculum and intensive research training focuses on real-world problem-solving, equipping graduates with the essential combination of technical expertise and the strategic vision necessary for leadership,” Kumar said. “Our graduates are prepared not just for the next job, but to effectively tackle the world’s most complex challenges, making a significant and positive impact on society.”